| Literature DB >> 28100409 |
Keiichi Nakahara1, Shunya Nakane2, Makoto Nakajima3, Satoshi Yamashita4, Takeshi Mori5, Yukio Ando6.
Abstract
To clarify the efficacy of thymectomy among myasthenia gravis (MG) patients with and without thymoma. We classified MG patients who underwent thymectomy into 3 groups, such as thymic atrophy group, thymic follicular hyperplasia (TFH) group and thymoma group. We compared the data of clinical features and postoperative prognosis at very short-term, short-term, and medium-term. The clinical course of MG patients with atrophic thymus after thymectomy was even better than those of TFH or thymoma, in this retrospective study. However, we found no significant differences in the comparison of mean dose of prednisolone between the 3 groups at each time point.Entities:
Keywords: Anti-acetylcholine receptor antibody; Myasthenia gravis; Prednisolone; Thymectomy; Thymus pathology
Mesh:
Substances:
Year: 2017 PMID: 28100409 DOI: 10.1016/j.jneuroim.2017.01.005
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478